Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Market Closed
Updated:
Apr 29, 2024
Abcam PLC
Operating Income
|
Abcam PLC
Operating Income Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
Operating Income
£30.5m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-1%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Operating Income
-$171.3m
|
CAGR 3-Years
-154%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Operating Income
-$175.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Operating Income
-$189.4m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Operating Income
-£59.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Operating Income
£53m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
See Also
What is Abcam PLC's Operating Income?
Operating Income
30.5m
GBP
30.5m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Operating Income amounts to 30.5m GBP.
What is Abcam PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-1%
-1%
Over the last year, the Operating Income growth was -18%. The average annual Operating Income growth rates for Abcam PLC have been -27% over the past three years , -13% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
